PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Project: Non Profit

Project Details

StatusActive
Effective start/end date8/13/138/12/38

Funding

  • University of Michigan